-
1
-
-
0008055930
-
Summary of the Jungle By Upton Sinclair
-
SparkNotes Online Study Guide: (TheSpark.com Inc., Cambridge, MA)
-
(1999)
-
-
Ward, S.1
-
2
-
-
0008102284
-
-
Requirements of Laws and Regulations Enforced by the U.S. Food and Drug Administration (FDA, Rockville, MD)
-
(1997)
-
-
-
3
-
-
0008057349
-
-
Office of Women's Health, FDA Milestones in Women's Health: Looking Back as We Move into the New Millennium (FDA, Rockville, MD)
-
(2000)
-
-
-
4
-
-
0008103769
-
-
FDA History: FDA Commissioners and Their Predecessors, U.S. Food and Drug Administration, Rockville, MD, rev.
-
(2000)
-
-
-
5
-
-
0008060738
-
Safety Assessment in Pediatrics
-
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
-
(1999)
-
-
Roberts, R.1
-
6
-
-
0008157384
-
-
Center for Drug Evaluation and Research, Time Line: Chronology of Drug Regulation in the United States (FDA, Rockville, MD)
-
-
-
-
7
-
-
0003441994
-
Milestones in U.S. Food and Drug Law History
-
FDA Backgrounder: Current and Useful Information from the Food and Drug Administration (FDA, Rockville, MD)
-
(1995)
-
-
-
8
-
-
0008105136
-
-
'Jonas Salk, MD - Biography' (American Academy of Achievement), Webster's New Collegiate Dictionary (G. and C. Merriam Company, Springfield, MA, 1975)
-
(2000)
-
-
-
10
-
-
0008105137
-
-
Code of Federal Regulations, Food and Drugs, 'Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs' revised April 2000, Title 21 Part 210-211 (U.S. Printing Office, Washington, DC)
-
-
-
-
11
-
-
0008060739
-
-
Code of Federal Regulations, Food and Drugs, 'Medical Devices: Current Good Manufacturing Practices (CGMP) Final Rule,' revised April 1999, Title 21 Part 820 (U.S. Printing Office, Washington, DC)
-
-
-
-
12
-
-
0008101758
-
-
Code of Federal Regulations, Food and Drugs, 'General: Good Laboratory Practice for Nonclinical Laboratory Studies' revised April 2000, Title 21 Part 58 (U.S. Printing Office, Washington, DC)
-
-
-
-
13
-
-
0008102285
-
Protecting Against Unwanted Pregnancy: A Guide to Contraceptive Choices
-
(1997)
FDA Consumer
, vol.31
, Issue.3
-
-
Nordenberg, T.1
-
15
-
-
84862496689
-
The Story of the Laws Behind the Labels, Part III: 1962 Drug Amendments
-
(1981)
FDA Consumer
-
-
-
16
-
-
0008141872
-
-
Office of Special Nutritionals, Overview of Infant Formulas (FDA, Center for Food Safety and Applied Nutrition, Washington DC)
-
(1997)
-
-
-
17
-
-
0008150964
-
The tylenol crisis: How effective public relations saved Johnson and Johnson
-
(Penn State University Personal Web Pages, PA)
-
(1998)
-
-
Kaplan, T.1
-
18
-
-
0008151977
-
-
National Center for Drugs and Biologics, 'Guide to Inspection of Computerized Systems in Drug Processing' (FDA, Rockville, MD)
-
(1983)
-
-
-
19
-
-
0008057350
-
-
Center for Drug Evaluation and Research, 'Guideline on General Principles of Process Validation' (FDA, Rockville, MD)
-
(1987)
-
-
-
20
-
-
0008101581
-
-
Center for Food Safety and Applied Nutrition, FDA Talk Paper: Impurities Confirmed in Dietary Supplement 5-Hydroxy-L-Tryptophan (FDA, Washington, DC)
-
(1998)
-
-
-
21
-
-
0008057490
-
-
Center for Biologics Evaluation and Research, 'Draft Guidance for Industry: Manufacturing, Processing, or Holding of Active Pharmaceutical Ingredients' (FDA, Rockville, MD)
-
(1998)
-
-
-
23
-
-
0008057941
-
-
Commissioner of Food and Drugs, Hastings Lecture (Washington, DC)
-
(1993)
-
-
Kessler, D.A.1
-
24
-
-
0008148045
-
Shiley annual hospital administrator letter: Heart valve program
-
(Pfizer Inc., New York)
-
(1998)
-
-
Sciacca, S.1
-
25
-
-
0008101759
-
-
Office of Regulatory Affairs, Guide to Inspections of Quality Systems (FDA Rockville. MD)
-
(1999)
-
-
-
26
-
-
0001184885
-
-
International Conference on Harmonisation, Guide for Industry: E6, Good Clinical Practice Consolidated Guidance (Geneva, Switzerland), April 1996. Published in the FederalRegister
-
(1997)
, vol.62
, Issue.90
, pp. 25691-25709
-
-
-
27
-
-
0008102287
-
-
Draft Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production, (FDA, Rockville, MD)
-
(1998)
-
-
-
28
-
-
0008062364
-
-
Office of Regulatory Affairs Compliance Reference: Debarment List, (FDA, Rockville, MD)
-
-
-
-
30
-
-
0008105140
-
-
Office of Regulatory Affairs Compliance Reference: Bioresearch Monitoring (BIMO) Disqualified/Restrictead/Assurance List for Clinical Investigators, (FDA, Rockville, MD)
-
-
-
-
31
-
-
0004038963
-
New initiatives to protect participants in Gene Therapy Trials
-
HHS Press Release, CBER (FDA, Rockville, MD)
-
(2000)
-
-
|